{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001525147,0.001019139,0.006139294,0.001214307,0.000259822,0.0001356932,0.0002211797,0.0002928665,0.001224201],"category_scores_gemma":[0.00007695355,0.0005738579,0.0008020054,0.001811965,0.0003246742,0.0002195302,0.0002261682,0.000651088,0.000006799866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002171867,"about_ca_system_score_gemma":0.002634907,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02497208,"about_ca_topic_score_gemma":0.01814345,"domain_scores_codex":[0.9931951,0.0017094,0.001234843,0.001357916,0.001501007,0.001001792],"domain_scores_gemma":[0.9959592,0.00130508,0.0006380008,0.0006701995,0.0006945771,0.0007329952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.02469307,0.00370095,0.03466239,0.002196913,0.1648153,0.0001840057,0.0002883394,0.000003070931,2.53549e-7,0.000008090458,0.0004849132,0.7689627],"study_design_scores_gemma":[0.1427883,0.009544821,0.130695,0.003384272,0.5642329,0.0001414527,0.000170889,0.00005293492,0.00000127879,0.0001297872,0.1472784,0.001579911],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006154077,0.9711132,0.000003178971,0.001241191,0.0002909236,0.006781202,0.01430797,0.00004362248,0.0000646574],"genre_scores_gemma":[0.01092735,0.9771853,0.00009186485,0.00001556098,0.0005241415,0.006572264,0.002491525,0.0001151877,0.002076776],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7673829,"threshold_uncertainty_score":0.9997728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}